Transverse Medical Inc. (TMI) is developing the POINT-GUARD™ Dynamic Cerebral Embolic Protection (CEP) medical device to address the devastating and costly problem of stroke during the large and growing number of heart valve procedures that occur annually around the world, such as Transcatheter Aortic Valve Replacement (TAVR).

Medical Devices

Transverse Medical

Transverse Medical's headquarters in Denver, CO, United States

Eric Goslau

Erin Spiegel

Stan Lapidus

Carl St. Bernard

Ted Tarasow

Dan Estay

Bill Goslau

Samir Kapadia

Axel Linke

David K. Stone

Michael Reardon

The Clinical Affairs Team at Transverse Medical is responsible for designing and overseeing clinical studies to evaluate the safety and efficacy of the POINT-GUARD™ Dynamic Cerebral Embolic Protection device. This team collaborates closely with regulatory agencies, medical professionals, and internal stakeholders to ensure compliance with clinical guidelines while supporting the advancement of innovative solutions to prevent stroke during heart valve procedures.

Clinical Affairs Team

The Leadership Team at Transverse Medical is responsible for guiding the strategic vision and operational direction of the company. This team, comprised of co-founders and executives, focuses on driving innovation in the development of the POINT-GUARD™ device, fostering partnerships, ensuring regulatory compliance, and positioning the company for growth in the medical device market while addressing critical healthcare challenges related to stroke prevention during heart valve procedures.

Transverse Medical

Org chart

Board & advisors

Teams

Clinical Affairs Team

Leadership Team

Offices

Transverse Medical

Org chart

Board & advisors

Teams

Clinical Affairs Team

Leadership Team

Offices

Related companies